DIABETES MELLITUS 2: CARDIOVASCULAR RISK FACTORS AND DRUG TREATMENTS IN PRIMARY CARE IN SPAIN

被引：0
|
作者：
Mantilla, T.
Lorenzo, A.
Garcia, B.
机构：
[1] Natl Spanish Hlth, Hlth Clin Prosperidad, Madrid, Spain
[2] Natl Spanish Hlth, Hlth Clin Alcala de Guadaira, Madrid, Spain
[3] Natl Spanish Hlth, Hlth Clin Benita de Avila, Madrid, Spain
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Features of the risk profile of patients with type 2 diabetes and/or cardiovascular disease in a primary care centre in Barcelona (Spain)
    Canivell, Silvia
    Ortiz, Jacinto
    Mitjavila, Joan
    Otero, Xavier
    Sotoca, Jose M.
    Gomis, Ramon
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2012, 24 (05): : 234 - 240
  • [22] Risk factors for development of impaired renal function in Type 2 diabetes mellitus patients in primary care
    Naushahi, MJ
    de Grauw, WJC
    Avery, AJ
    van Gerwen, WHEM
    van de Lisdonk, EH
    van Weel, C
    DIABETIC MEDICINE, 2004, 21 (10) : 1096 - 1101
  • [23] Management of diabetes mellitus and associated cardiovascular risk factors in Brazil – the Brazilian study on the practice of diabetes care
    Juarez R Braga
    Alvaro Avezum
    Sandra RG Ferreira
    Adriana Forti
    Diabetology & Metabolic Syndrome, 5
  • [24] Management of diabetes mellitus and associated cardiovascular risk factors in Brazil - the Brazilian study on the practice of diabetes care
    Braga, Juarez R.
    Avezum, Alvaro
    Ferreira, Sandra R. G.
    Forti, Adriana
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [25] Cardiovascular risk management in diabetes in primary care
    Kalra, Sanjay
    Gupta, Yashdeep
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (08) : 907 - 908
  • [26] Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2
    Alcocer-Gamba, Marco A.
    Gutierrez-Fajardo, Pedro
    Sosa-Caballero, Alejandro
    Cabrera-Rayo, Alfredo
    Faradji-Hazan, Raquel N.
    Padilla-Padilla, Francisco G.
    Garnica-Cuellar, Juan C.
    Hernandez-Arispe, Leticia M.
    Reyes-Cianeros, Fernando A.
    Leon-Suarez, Andres
    De-Jesus-Rivera, Jose
    Mancillas-Adame, Leonardo
    Gaxiola-Macias, Manuel
    Marquez-Rodriguez, Eduardo
    Miranda-Malpica, Emma
    Sanchez-Pedraza, Valentin
    Lara-Martinez, Daniel S.
    Segovia-Palomo, Antonio
    Nava-Hernandez, Angeles
    Rivera-Reyes, Romina
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2020, 90 : 77 - 83
  • [27] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [28] Risk factors for cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients
    Semyatichko, E.
    Nemtsova, V.
    Feclina, I.
    JOURNAL OF NEUROLOGY, 2007, 254 : 110 - 110
  • [29] Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors
    Hayden, JM
    Reaven, PD
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (05) : 519 - 528
  • [30] Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus
    El Eter, E.
    Al-Masri, A. A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (05) : 465 - 469
12345